Acadia Pharmaceuticals (ACAD) Net Margin (2010 - 2026)
Acadia Pharmaceuticals' (ACAD) quarterly Net Margin came in at 1.36% in Q1 2026, down 641.0% year-on-year from 0.25% in Q1 2025, and down 98.59% quarter-over-quarter from 96.33% in Q4 2025.
Acadia Pharmaceuticals (ACAD) Net Margin (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Net Margin history runs 17 years deep, the most recent figure standing at 1.36% for Q1 2026.
- On a quarterly basis, Net Margin fell 641.0% year-over-year to 1.36% in Q1 2026; TTM through Mar 2026 was 34.3%, a 1132.0% increase from a year earlier, with the FY2025 full-year figure at 36.49%, up 1285.0% from the prior year.
- Net Margin fell to 1.36% in Q1 2026 per ACAD's latest filing, from 96.33% in the prior quarter.
- Across five years, Net Margin topped out at 96.33% in Q4 2025 and bottomed at 97.91% in Q1 2022.
- The 5-year median for Net Margin is 7.77% (2025), against an average of 0.62%.
- Across the five-year window, Net Margin plunged 3555 bps in 2022 and soared 6159 bps in 2023, its largest moves.
- Year by year, Net Margin stood at 30.51% in 2022, then soared by 165 bps to 19.82% in 2023, then soared by 179 bps to 55.37% in 2024, then soared by 74 bps to 96.33% in 2025, then slumped by 99 bps to 1.36% in 2026.
- Per Business Quant, the three latest ACAD Net Margin figures stand at 1.36% (Q1 2026), 96.33% (Q4 2025), and 25.76% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | 1.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.36% |
| Dec 31, 2025 | 96.33% |
| Sep 30, 2025 | 25.76% |
| Jun 30, 2025 | 10.08% |
| Mar 31, 2025 | 7.77% |
| Dec 31, 2024 | 55.37% |
| Sep 30, 2024 | 13.09% |
| Jun 30, 2024 | 13.80% |
| Mar 31, 2024 | 8.04% |
| Dec 31, 2023 | 19.82% |
| Sep 30, 2023 | -30.79% |
| Jun 30, 2023 | 0.67% |
| Mar 31, 2023 | -36.32% |
| Dec 31, 2022 | -30.51% |
| Sep 30, 2022 | -20.78% |
| Jun 30, 2022 | -25.28% |
| Mar 31, 2022 | -97.91% |
| Dec 31, 2021 | -35.66% |
| Sep 30, 2021 | -10.98% |
| Jun 30, 2021 | -38.08% |